Presentation of full TG01 phase I/II clinical trial results
in resected pancreatic cancer, by Professor Daniel Palmer
Update on the TG mutRAS neoantigen vaccine development
strategy
Review of recent ONCOS-102 interim data in melanoma and
mesothelioma
OSLO, Norway,
Oct. 4, 2018 /PRNewswire/ --
Targovax ASA (OSE: TRVX), a clinical stage biotechnology
company developing immune activators to target hard to treat solid
tumors, announces that it will host a Capital Markets Day in
Oslo on Monday 15 October 2018, from 08:30 – 10:30
The event will include a presentation by a world leading expert
on pancreatic cancer, Professor Daniel
Palmer, who is the Chair of Medical Oncology at the
University of Liverpool and
Clatterbridge Cancer Centre. Professor Palmer has been involved in
a number of large international clinical studies in pancreatic
cancer, and was the Principal Investigator of Targovax's TG01 phase
I/II trial in resected pancreatic cancer, in combination with
adjuvant gemcitabine. Top-line survival data from the trial were
released in May 2018 (see press
release here) and at the upcoming event Professor Palmer will
present the full study results.
Øystein Soug, CEO of Targovax, will give an update on the TG
mutRAS neoantigen vaccine development strategy.
There will also be an update on the ongoing ONCOS oncolytic
virus program, including a review of recent interim read-outs from
the ONCOS-102 clinical trials in mesothelioma and melanoma, by
Magnus Jäderberg, CMO of Targovax.
Event venue: Hotel Continental, Oslo,
Norway
Date: 15 October 2018
Time: 08:30 – 10:30 CET
A live webcast of the symposium will be available in the Events
and Presentations section of the Targovax website.
To register for the event, please contact
renate.birkeli@targovax.com.
CONTACT:
For further information, please contact:
Renate Birkeli, Investor
Relations
Phone: +47 922 61 624
Email: renate.birkeli@targovax.com
Media and IR enquires:
Andreas Tinglum - Corporate
Communications (Norway)
Phone: +47 9300 1773
Email: andreas.tinglum@corpcom.no
Simon Conway/Stephanie Cuthbert - FTI Consulting
(International)
Phone: +44 20 3727 1000
Email: Targovax@fticonsulting.com
This information was brought to you by Cision
http://news.cision.com
http://news.cision.com/targovax/r/targovax-to-host-capital-markets-day-15-october-2018--in-oslo--norway,c2634755